TABLE 2.
Probe set | Description | Flag (N/C)a | Normalized valueb | Fold change |
---|---|---|---|---|
Increased | ||||
204621_s_at | Nurr1 (Nuclear receptor subfamily 4 group A member 2) | P/(A) | 26.1 | 26.1 |
210663_s_at | Kynurenidase (l-kyurenine hydrolase) | P/(A) | 60.7 | 9.6 |
204430_s_at | Solute carrier family 2 (facilitated glucose/fructose transporter), member 5 | P/(A) | 9.3 | 9.3 |
205921_s_at | Solute carrier family 6 (neurotransmitter transporter, taurine), member 6 | P/(A) | 6.2 | 6.2 |
205156_s_at | ACCN2 (amiloride-sensitive cation channel 2, neuronal) | P/(A) | 4.1 | 3.4 |
204846_at | Ceruloplasmin (ferroxidase) | P/(A) | 12.2 | 2.6 |
202507_s_at | Synaptosome-associated protein, 25 kDa | P/(A) | 1.5 | 1.5 |
205792_at | WNT1-inducible signaling pathway protein 2 | P/(P) | 12.4 | 12.4 |
213425_s_at | WNT5A (wingless-type MMTVc integration site family, member 5A) | P/(P) | 4.3 | 7.1 |
207594_s_at | Synaptojanin 1 | P/(P) | 3.3 | 6.1 |
211806_s_at | Potassium inwardly rectifying channel | P/(A) | 2.5 | 2.5 |
211592_s_at | Calcium channel, voltage-dependent, L type | P/(A) | 0.9 | 2.3 |
214933_at | Calcium channel, voltage-dependent, P/Q type | P/(A) | 1.0 | 1.4 |
Decreased | ||||
214081_at | Tumor endothelial marker 7 | A/(P) | 0.2 | −19.5 |
209287_s_at | Cdc42 effector protein | A/(P) | 0.1 | −11.0 |
206898_at | Cadoherin 19, type 2 | A/(P) | 0.9 | −7.1 |
205132_at | Actin alpha, cardiac muscle | A/(P) | 0.1 | −7.0 |
204736_s_at | Chondroitin 4-sulfotransferase | A/(P) | 0.3 | −5.0 |
209652_s_at | Placental growth factor, VEGF-related protein | A/(P) | 1.0 | −3.2 |
215177_s_at | Integrin alpha 6 | A/(P) | 0.5 | −2.6 |
N, neuronally differentiated UE7T-13 cells; C, undifferentiated UE7T-13 cells; P, judged to be “present” (expressed) in neuronally differentiated UE7T-13 cells; A, judged to be “absent” (not expressed) in undifferentiated UE7T-13 cells.
The normalized values were calculated from data obtained in UE7T-13 cells as described in Material and Methods.
MMTV, mouse mammary tumor virus.